Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,762 | 5,008 | 7,371 | 3,204 | 199 |
| TOTAL | $2,835 | $5,073 | $7,482 | $3,424 | $557 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 3 | 3 | 2 |
| Investments And Advances | 2 | 2 | 2 | 2 | 2 |
| Intangibles | 1,587 | 1,587 | 1,587 | 1,587 | 1,587 |
| Other Non-Current Assets | 19,400 | 19,400 | 19,400 | 19,400 | 19,420 |
| TOTAL | $20,991 | $20,991 | $20,992 | $20,992 | $21,011 |
| Total Assets | $23,826 | $26,064 | $28,473 | $24,417 | $21,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 912 | 1,401 | 561 | 602 | 1,978 |
| Accrued Expenses | 1,105 | 988 | 1,865 | 1,666 | 1,971 |
| Other current liabilities | N/A | N/A | 18 | 28 | 609 |
| TOTAL | $2,190 | $2,562 | $2,617 | $2,469 | $9,973 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,190 | $2,562 | $2,617 | $2,469 | $9,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 648 | 427 | 399 | 337 | 330 |
| Common Shares | 11 | 11 | 10 | 8 | 5 |
| Retained earnings | -37,411 | -35,389 | -30,967 | -27,721 | -24,678 |
| TOTAL | $21,635 | $23,502 | $25,856 | $21,947 | $11,594 |
| Total Liabilities And Equity | $23,826 | $26,064 | $28,473 | $24,417 | $21,567 |